Pulsed terbinafine may be best option for some with toenail onychomycosis

Article

Washington - The therapy of choice for the treatment of toenail onychomycosis remains continuous doses of terbinafine (Lamisil), according to Erin Warshaw, M.D. In certain situations, however, pulse dosing may play a role.

Related Videos
Related Content

The Dermatologists' Role in Health Care & Legislative Advocacy ft. Marty Makary, MD, MPH, FACS

September 21st 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Hidradenitis Suppurativa May Lead to Skin Changes, Peripheral Neuropathy

September 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Delays UCB’s Bimekizumab Approval

September 20th 2023

Considerations for Preventing and Addressing Alopecia in Patients With Religious Headwear

September 20th 2023

The Dermatologists' Role in Health Care & Legislative Advocacy ft. Marty Makary, MD, MPH, FACS

September 21st 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Hidradenitis Suppurativa May Lead to Skin Changes, Peripheral Neuropathy

September 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Delays UCB’s Bimekizumab Approval

September 20th 2023

Considerations for Preventing and Addressing Alopecia in Patients With Religious Headwear

September 20th 2023

The Dermatologists' Role in Health Care & Legislative Advocacy ft. Marty Makary, MD, MPH, FACS

September 21st 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Hidradenitis Suppurativa May Lead to Skin Changes, Peripheral Neuropathy

September 21st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Delays UCB’s Bimekizumab Approval

September 20th 2023

Considerations for Preventing and Addressing Alopecia in Patients With Religious Headwear

September 20th 2023
© 2023 MJH Life Sciences

All rights reserved.